Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline

2019/02/05 by Cesare Hassan, Piotr Wysocki, Lorenzo Fuccio +24 · 95 citations
Medicine · #Cancer #Colonoscopy #Colorectal Cancer Screening and Detection #Colorectal Cancer Surgical Treatments #Colorectal cancer #Endoscopic mucosal resection #Endoscopy #Gastric Cancer Management and Outcomes #General surgery #Guideline #Internal medicine #Medicine #Pathology #Perioperative #Surgery

paper · pdf · doi:10.1055/a-0831-2522

published in Endoscopy 51(03), 266-277 (Thieme Medical Publishers (Germany))

openalex publication_date 2019/02/05 · openalex created_date 2019/02/21 · openalex updated_date 2026/08/04

Abstract

1: We recommend post-surgery endoscopic surveillance for CRC patients after intent-to-cure surgery and appropriate oncological treatment for both local and distant disease.Strong recommendation, low quality evidence. 2: We recommend a high quality perioperative colonoscopy before surgery for CRC or within 6 months following surgery.Strong recommendation, low quality evidence. 3: We recommend performing surveillance colonoscopy 1 year after CRC surgery.Strong recommendation, moderate quality evidence. 4: We do not recommend an intensive endoscopic surveillance strategy, e. g. annual colonoscopy, because of a lack of proven benefit.Strong recommendation, moderate quality evidence. 5: After the first surveillance colonoscopy following CRC surgery, we suggest the second colonoscopy should be performed 3 years later, and the third 5 years after the second. If additional high risk neoplastic lesions are detected, subsequent surveillance examinations at shorter intervals may be considered.Weak recommendation, low quality evidence. 6: After the initial surveillance colonoscopy, we suggest halting post-surgery endoscopic surveillance at the age of 80 years, or earlier if life-expectancy is thought to be limited by comorbidities.Weak recommendation, low quality evidence. 7: In patients with a low risk pT1 CRC treated by endoscopy with an R0 resection, we suggest the same endoscopic surveillance schedule as for any CRC.Weak recommendation, low quality evidence.

Cited by

• Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis
• British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines
• Endoscopic removal of colorectal T1 cancers: Why is a 1-year follow-up recommended by ESGE when resection is R0 and curative? [europepmc]
• Endoscopic full-thickness resection of colorectal lesions with the full-thickness resection device: clinical experience from two referral centers in Greece. [europepmc]
• Endoscopic mucosal resection with anchoring of the snare tip: multicenter retrospective evaluation of effectiveness and safety. [europepmc]
• British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. [europepmc]
• COVID-19 and endoscopy: implications for healthcare and digestive cancer screening. [europepmc]
• Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergency. [europepmc]
• Efficacy of endoscopic surveillance in the detection of local recurrence after radical rectal cancer surgery is limited? A retrospective study. [europepmc]
• The Importance of Being "That" Colorectal pT1: A Combined Clinico-Pathological Predictive Score to Improve Nodal Risk Stratification. [europepmc]
• Appropriateness of high-priority criteria and safety of endoscopy procedures during the COVID-19 lockdown. [europepmc]
• OPPORTUNISTIC SCREENING FOR COLORECTAL CANCER IN HIGH-RISK PATIENTS IN FAMILY MEDICINE PRACTICES IN THE REPUBLIC OF CROATIA. [europepmc]
• Real-time artificial intelligence (AI)-aided endoscopy improves adenoma detection rates even in experienced endoscopists: a cohort study in Singapore. [europepmc]
• Normal Gastrointestinal Mucosa at Biopsy and Overall Mortality: Nationwide Population-Based Cohort Study. [europepmc]
• Clinically Significant Metachronous Colorectal Pathology Detected Among Young-Onset Colorectal Cancer Survivors: Implications for Post-Resection Surveillance Guidelines. [europepmc]
• Detection and Yield of Colorectal Cancer Surveillance in Adults with PTEN Hamartoma Tumour Syndrome. [europepmc]
• Malignant psoas syndrome and bilateral hydronephrosis without evident obstruction in colorectal cancer. [europepmc]
• Risk factors for synchronous high-risk polyps in patients with colorectal cancer. [europepmc]
• Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection. [europepmc]
• Risk of metachronous colorectal cancer associated with polypectomy during endoscopic diagnosis of colorectal cancer. [europepmc]
• Impact of narrow band imaging in prediction of histology of advanced colorectal neoplasia. [europepmc]
• Organ preservation in rectal cancer: opportunity within boundaries. [europepmc]
• Interobserver variability of histopathological assessment in pT1 colorectal carcinoma. [europepmc]

Related

• British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines
• Use of computer-assisted detection (CADe) colonoscopy in colorectal cancer screening and surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
• Diagnostic consequence of colonoscopy repeated within 3 years at a tertiary hospital: a single‐centre observational study
• Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer
• The risk of lymph node metastasis makes it unsafe to expand the conventional indications for endoscopic treatment of T1 colorectal cancer